• home
  • about us
    • the advantage
    • key facts
    • where we are
    • where we invest
    • management team
    • funds
  • portfolio
    • companies
    • CEOs
  • news
  • investments
    • focus
      • prevention & nutraceuticals
      • medical foods OTC, Rx
      • enabling technologies
      • brands & channels
      • diagnostics
    • criteria
    • process
  • your business
  • careers
  • contact us
    • the bahamas
    • united kingdom
    • switzerland
    • new zealand

about us

key facts

  • Founded 2000
  • Currently operating from four locations:
    • Geneva, Switzerland
    • Nassau, Bahamas
    • Auckland, New Zealand
    • London, United Kingdom
  • Close ties and good business relations with
    • Top-tier pharmaceutical companies
    • Top tier nutrition companies
    • Universities
    • Private equity groups
    • Investments banks
  • $1.5 billion under management
  • Large global portfolio, of our investments
    • 42.5% North America, 42.5% EU, 15% Austral-Asia
Martin Welschof, Opsona
Martin Welschof, Opsona:
"Inventages had the vision and courage to support Opsona's quest to develop first in class and revolutionary treatment option targeting key structures of the innate immune system." More...
Terms Print Top
© 2012 Inventages